iRadimed's Earnings Outlook
Portfolio Pulse from Benzinga Insights
iRadimed (NASDAQ:IRMD) is scheduled to release its quarterly earnings report on February 8, 2024, with analysts expecting an EPS of $0.40. The company's historical earnings performance shows a mix of beats and misses, with the share price reacting variably. Shares are currently trading at $45.77, up 27.7% over the last year. Investors are looking for not just an earnings beat but also positive guidance for future growth.
February 07, 2024 | 6:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
iRadimed is expected to report an EPS of $0.40 for the upcoming quarter, with historical performance showing a mix of earnings beats and minor share price reactions. The stock has seen a 27.7% increase over the past year.
Given iRadimed's history of beating EPS estimates and the stock's positive performance over the past year, there's a high likelihood of a positive short-term impact on IRMD's stock price, especially if the company beats the EPS estimate again and provides optimistic future guidance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100